Pinsent Masons advises on £15.2m main market IPO of Rainbow Rare Earths Ltd
30 Jan 2017 | 10:49 am |
International law firm Pinsent Masons has advised Hannam & Partners and Daniel Stewart & Company Plc as joint bookrunners on the £15.2m main market IPO of Rainbow Rare Earths Ltd.
Rainbow Rare Earths Ltd is a Guernsey incorporated rare earth development company operating in East Africa with a specific focus on Burundi and the company's shares were admitted to trading on 30 January.
The Pinsent Masons team acting on the transaction was led by partner Jon Harris and senior associate Adam Cain with assistance from solicitor Dan Hickie.
Commenting on the listing of Rainbow Rare Earths Ltd, Jon Harris, said:
"We are delighted to have worked on this main market IPO, our first completed IPO of 2017."
Key Contacts
Latest press releases
Show me all press releasesPinsent Masons advises Bodymed AG on the sale to Nestlé Health Science
The multinational law firm Pinsent Masons advises the holding company of the founder Dr Hardy Walle on the sale of all shares of Bodymed AG to Nestlé Health Science.
Pinsent Masons secures 11th place in Financial Times Diversity Leaders 2021 Report
Multinational law firm Pinsent Masons has been named as a top 20 Diversity Leader by the Financial Times, ranked 11th in its Diversity Leaders 2021 report.
Pinsent Masons advises shareholders of Goodtill on its sale to SumUp
Multinational law firm Pinsent Masons has advised the shareholders of Goodtill on its sale to SumUp
People who viewed this press release also viewed
Show me all press releasesPinsent Masons advises Bodymed AG on the sale to Nestlé Health Science
The multinational law firm Pinsent Masons advises the holding company of the founder Dr Hardy Walle on the sale of all shares of Bodymed AG to Nestlé Health Science.
Pinsent Masons advises shareholders of Goodtill on its sale to SumUp
Multinational law firm Pinsent Masons has advised the shareholders of Goodtill on its sale to SumUp
Pinsent Masons advises 4D Pharma PLC on innovative move to NASDAQ
Multinational law firm Pinsent Masons has advised AIM listed biotech company 4D Pharma plc (4D) on its acquisition of Longevity Acquisition Corporation, a special-purpose acquisition company (SPAC) listed on NASDAQ. Upon completion of the transaction 4D will apply for its American Depositary Shares to be admitted to trading on NASDAQ.
For all media enquiries, including arranging an interview with one of our spokespeople, please contact the press office on
Location contacts
Europe: [email protected]
Asia: [email protected]
Middle East: [email protected]
Australia: [email protected]